4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-017970
Director sold 1,666 shares at an average $61.61 ($102,641)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2021-03-03 | Sale | −235 | $60.36 | $14,185 | 140,518 | D |
| SATO VICKI L Director | 2021-03-03 | Sale | −1,050 | $61.52 | $64,600 | 139,468 | D |
| SATO VICKI L Director | 2021-03-03 | Sale | −266 | $62.29 | $16,569 | 139,202 | D |
| SATO VICKI L Director | 2021-03-03 | Sale | −115 | $63.37 | $7,287 | 139,087 | D |
| Open-market sales · 1,666 sh · avg $61.61 · $102,641 | |||||||
Loading xslF345X03/doc4.xml…